Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-005095

Chief Financial Officer sold 4,000 shares at $215.00 ($860,000)

From the SEC's structured data for this filing

Trades in this filing

Sandercock Brett · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-13 Sale : show line 1 in the form −4,000 $215.00 $860,000 116,880 D
Open-market sales · 4,000 sh · avg $215.00 · $860,000
Loading xslF345X03/form4.xml…